{"id":9501,"date":"2025-12-11T06:55:35","date_gmt":"2025-12-11T06:55:35","guid":{"rendered":"https:\/\/lemonn.co.in\/blog\/?p=9501"},"modified":"2025-12-11T06:55:38","modified_gmt":"2025-12-11T06:55:38","slug":"corona-remedies-ipo-allotment-status-gmp","status":"publish","type":"post","link":"https:\/\/lemonn.co.in\/blog\/ipo\/corona-remedies-ipo-allotment-status-gmp\/","title":{"rendered":"Corona Remedies IPO Allotment Status: Check Latest GMP, Steps To Verify Status"},"content":{"rendered":"
\"\"<\/figure>\n\n\n

Corona Remedies\u2019 IPO has generated strong buzz thanks to its performance in the Indian pharma sector. If you applied, here\u2019s how to check your allotment status<\/strong>, view the latest GMP<\/strong>, and understand what happens next<\/strong>.<\/p>\n\n\n\n

How to Check Corona Remedies IPO Allotment Status<\/h2>\n\n\n\n

The allotment process usually wraps up a few days after the IPO closes. You can check your status using your PAN, application number, or DP ID.<\/p>\n\n\n\n

Method 1: Registrar Website<\/h3>\n\n\n\n
    \n
  1. Visit the registrar\u2019s IPO allotment portal.<\/li>\n\n\n\n
  2. Choose Corona Remedies Limited<\/strong> from the dropdown.<\/li>\n\n\n\n
  3. Select your preferred option: PAN \/ Application Number \/ DP ID.<\/li>\n\n\n\n
  4. Enter details and complete the captcha.<\/li>\n\n\n\n
  5. Click Submit<\/strong>.<\/li>\n<\/ol>\n\n\n\n

    You’ll see if shares were allotted to you or not.<\/p>\n\n\n\n

    Method 2: BSE Website<\/h3>\n\n\n\n
      \n
    1. Go to bseindia.com\/investors\/appli_check.aspx<\/a><\/li>\n\n\n\n
    2. Select \u201cEquity\u201d and then Corona Remedies<\/strong>.<\/li>\n\n\n\n
    3. Enter your application number and PAN.<\/li>\n\n\n\n
    4. Click Search<\/strong> to view status.<\/li>\n<\/ol>\n\n\n\n

      Corona Remedies IPO GMP Today (as of December 11, 2025)<\/h2>\n\n\n\n

      Grey Market Premium (GMP) gives an early indication of listing expectations. While unofficial, it reflects current market demand.<\/p>\n\n\n\n

        \n
      • Latest GMP<\/strong>: \u20b9295 per share<\/li>\n\n\n\n
      • Issue Price<\/strong>: \u20b91,062 per share<\/li>\n\n\n\n
      • Estimated Listing Price<\/strong>: \u20b91,357 per share<\/strong><\/li>\n<\/ul>\n\n\n\n

        A strong GMP hints at potential listing-day gains but remember – it\u2019s not guaranteed.<\/p>\n\n\n\n

        Key Corona Remedies IPO Dates (Tentative)<\/h2>\n\n\n\n
        Event<\/th>Date<\/th><\/tr><\/thead>
        IPO Open Date<\/strong><\/td>December 4, 2025<\/td><\/tr>
        IPO Close Date<\/strong><\/td>December 6, 2025<\/td><\/tr>
        Allotment Finalization<\/strong><\/td>December 9, 2025<\/td><\/tr>
        Refunds Initiated<\/strong><\/td>December 10, 2025<\/td><\/tr>
        Shares Credited to Demat<\/strong><\/td>December 11, 2025<\/td><\/tr>
        Listing Date<\/strong><\/td>December 12, 2025<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

        Corona Remedies IPO Subscription Data (Final as of 10\u202fDec\u202f2025)<\/strong><\/h3>\n\n\n\n

        The Corona Remedies IPO saw exceptional investor interest<\/strong> across all categories. By the close of bidding on December\u202f10,\u202f2025<\/strong>, the subscription figures were:<\/p>\n\n\n\n

        Overall Subscription:<\/strong> ~144.49\u202f\u00d7<\/strong>\u202foversubscribed
        (with bids ~62.65\u202fcrore shares vs ~45.72\u202flakh shares on offer)<\/p>\n\n\n\n

        Breakdown by Category:<\/strong><\/p>\n\n\n\n

          \n
        • QIB (Qualified Institutional Buyers):<\/strong> ~293.8\u202f\u00d7<\/strong><\/li>\n\n\n\n
        • HNI (High Net Worth Investors):<\/strong> ~220.18\u202f\u00d7<\/strong><\/li>\n\n\n\n
        • Retail Investors:<\/strong> ~30.29\u202f\u00d7<\/strong><\/li>\n\n\n\n
        • Employees:<\/strong> ~15.56\u202f\u00d7<\/strong><\/li>\n<\/ul>\n\n\n\n

          These figures show strong demand from all investor segments \u2014 especially institutional investors \u2014 making it one of the most strongly subscribed pharma IPOs in the period.<\/p>\n\n\n\n

          Didn\u2019t Get the Allotment?<\/h2>\n\n\n\n

          If your application wasn\u2019t selected:<\/p>\n\n\n\n

            \n
          • Refunds will be processed automatically to your bank account.<\/li>\n\n\n\n
          • You can still buy Corona Remedies shares on the listing day\u2014but at the market price.<\/li>\n<\/ul>\n\n\n\n

            FAQs<\/h2>\n\n\n
            \n
            \n
            \n

            Q. What does Corona Remedies do?<\/h3>\n
            \n\n

            It\u2019s a leading Indian pharmaceutical company offering generic and branded medications across multiple therapy areas.<\/p>\n\n<\/div>\n<\/div>\n

            \n

            Q. Can I apply again if I didn\u2019t get allotment?<\/h3>\n
            \n\n

            No\u2014IPOs are one-time offers. But you can buy shares in the secondary market after listing.<\/p>\n\n<\/div>\n<\/div>\n

            \n

            Q. Is GMP reliable?<\/h3>\n
            \n\n

            Not always. GMP is speculative and changes frequently. It\u2019s a sentiment tracker\u2014not a sure forecast.<\/p>\n\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n

            Summary<\/h2>\n\n\n\n
              \n
            • Use your PAN or application number to check the Corona Remedies IPO allotment status.<\/li>\n\n\n\n
            • GMP gives an idea of market demand but isn\u2019t a guarantee.<\/li>\n\n\n\n
            • Refunds and Demat credits happen shortly before listing day.<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"

              Corona Remedies\u2019 IPO has generated strong buzz thanks to its performance in the Indian pharma sector. If you applied, here\u2019s how to check your allotment status, view the latest GMP, and understand what happens next. How to Check Corona Remedies IPO Allotment Status The allotment process usually wraps up a few days after the IPO […]<\/p>\n","protected":false},"author":3,"featured_media":9498,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_ayudawp_aiss_exclude":false,"footnotes":""},"categories":[24],"tags":[],"class_list":["post-9501","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ipo"],"blocksy_meta":[],"_links":{"self":[{"href":"https:\/\/lemonn.co.in\/blog\/wp-json\/wp\/v2\/posts\/9501","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lemonn.co.in\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lemonn.co.in\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lemonn.co.in\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/lemonn.co.in\/blog\/wp-json\/wp\/v2\/comments?post=9501"}],"version-history":[{"count":1,"href":"https:\/\/lemonn.co.in\/blog\/wp-json\/wp\/v2\/posts\/9501\/revisions"}],"predecessor-version":[{"id":9502,"href":"https:\/\/lemonn.co.in\/blog\/wp-json\/wp\/v2\/posts\/9501\/revisions\/9502"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lemonn.co.in\/blog\/wp-json\/wp\/v2\/media\/9498"}],"wp:attachment":[{"href":"https:\/\/lemonn.co.in\/blog\/wp-json\/wp\/v2\/media?parent=9501"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lemonn.co.in\/blog\/wp-json\/wp\/v2\/categories?post=9501"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lemonn.co.in\/blog\/wp-json\/wp\/v2\/tags?post=9501"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}